Location History:
- Medford, MA (US) (2006)
- Arlington, MA (US) (2009 - 2023)
Company Filing History:
2 out of 49 
2 out of 1,309 
2 out of 6 
Years Active: 2006-2023
Title: Andrea M Olland: Innovator in Binding Molecule Technology
Introduction: Andrea M Olland, based in Medford, MA, is a distinguished inventor known for her groundbreaking contributions to the field of molecular binding technology. With a remarkable portfolio of six patents, her work emphasizes innovation in high-affinity binding domains that have significant implications in biomedical applications.
Latest Patents: One of Andrea’s notable inventions is a single domain binding molecule designed with the structure FW1-CDR1-FW2-HV2-FW3a-HV4-FW3b-CDR3-FW4. This invention focuses on Framework Regions (FW1, FW2, FW3a, FW3b, and FW4), Complementarity Determining Regions (CDR1 and CDR3), and Hypervariable Regions (HV2 and HV4) that possess amino acid sequences specifically defined to create a high affinity anti-human serum albumin (HSA) binding domain. This molecule showcases the potential for advancements in therapeutic applications.
Career Highlights: Andrea has made significant strides in her career, working for prestigious institutions such as the University Court of the University of Aberdeen and Wyeth. Her positions at these organizations have allowed her to push the boundaries of research and innovation in biotechnology.
Collaborations: Throughout her career, Andrea has collaborated with talented individuals including Caroline Barelle and Mischa Roland Muller. These partnerships have contributed to her success and the advancement of research in the field.
Conclusion: Andrea M Olland's innovative spirit and dedication to molecular research have established her as a noteworthy figure in the invention landscape. Her work with high-affinity binding molecules not only emphasizes her inventiveness but also paves the way for future advancements in medicine and biotechnology.